hematology

dollar sign pipeline
Biotech

Zealand sells rights to Takeda’s blood cancer drug for $100M

As the FDA mulls whether to approve Takeda and Protagonist’s rusfertide, Zealand sold its rights to the blood cancer drug in return for $100 million.
James Waldron Aug 13, 2026 5:05am
Graphic of a puzzle depicting both the US and Chinese flags with missing pieces bridging the two together

BMS inks $15B deal to bag Hengrui assets, tap China’s R&D speed

May 12, 2026 1:56am
reshuffle pipeline target reorganize shift change

Novartis nixes 6 ph. 1 assets, adds 2 new cancer candidates

Feb 4, 2026 12:09pm
Stars twinkling in the night sky

ASH: Star antibody sparkles in preview of possible ph. 3 success

Dec 7, 2025 9:40am
Graphic of a drop of blood made up of small data points and nodes

Roche's Flatiron Health debuts 6 new blood cancer data sets

Oct 29, 2025 9:00am
blood test money

ASH launches $12M fund for scientists who lose federal grants

Jun 10, 2025 4:32pm